🇺🇸 FDA

Intelligence · Clinical Pipeline

Oncology R&D Pipeline

Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Programs
5,568

Quick answer

Oncology: NovaPharmaNews indexes 5,568 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Top sponsors

Page 111 of 116

  1. DOTAREM 0,5 mmol/ml oplossing voor injectie in injectieflacons.

    Disc Medicine

    Breast Cancer

    approved small molecule active

    1 trial

  2. DS-8201a

    AstraZeneca AB

    Treatment of patients with HER2-positive breast cancer with or without brain metastasis

    approved small molecule active

    1 trial

  3. Dexamethasone

    The First People's Hospital of Lianyungang

    Carcinoma, Non-Small-Cell Lung

    approved small molecule terminated

    1 trial

  4. Dexamethasone

    The First People's Hospital of Lianyungang

    Pancreatic Cancer

    approved small molecule active

    1 trial

  5. Dexamethasone 4 mg tablets, Dexamethasone Phosphate 4 mg/ml Solution for Injection

    Disc Medicine

    Solid tumors

    approved small molecule active

    1 trial

  6. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule completed

    1 trial

  7. Dexmedetomidine

    United Therapeutics Europe Ltd

    Breast Cancer

    approved small molecule active

    1 trial

  8. Dexmedetomidine

    Peking University Third Hospital

    Breast Cancer

    approved small molecule completed

    1 trial

  9. Dexmedetomidine Group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    approved small molecule completed

    1 trial

  10. Dotarem®

    Guerbet

    Primary Brain Tumor

    approved small molecule completed

    1 trial

  11. Doxorubicin Accord 2 mg/ml koncentrat till infusionsvätska, lösning, Paclitaxel Accord 6 mg/ml koncentrat till infusionsvätska, lösning, Docetaxel Ebewe 10 mg/ml koncentrat till infusionsvätska, lösning, Epirubicin Accord 2 mg/ml injektions-/infusionsvätska, lösning, Sendoxan pulver till injektionsvätska, lösning

    The George Institute

    Breast cancer female NOS

    approved small molecule active

    1 trial

  12. Durvalumab

    AstraZeneca

    Solid Tumor

    approved small molecule completed

    1 trial

  13. ENZALUTAMIDE, DOCETAXEL, ABIRATERONE

    Fondazione Telethon ETS

    metastatic castration resistant prostate cancer without mutations of BRCA1/2 genes or unknown

    approved small molecule active

    1 trial

  14. ESTRIOL , ESTRADIOL HEMIHYDRATE, PROMESTRIENE, PROGESTERONE, ESTRADIOL VALERATE

    The George Institute

    Cervical cancer

    approved small molecule active

    1 trial

  15. Enhanced dermatologic management

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NSCLC (Advanced Non-small Cell Lung Cancer)

    approved other active

    1 trial

  16. Epirubicin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Hepatocellular

    approved small molecule active

    1 trial

  17. Etoposide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mantle Cell Lymphoma

    approved small molecule completed

    1 trial

  18. Fentanyl Buccal Tablet (FBT)

    Teva Pharma GmbH

    Cancer Pain

    approved small molecule terminated

    1 trial

  19. Fruquintinib

    Takeda

    Colorectal Cancer

    approved small molecule active

    1 trial

  20. GAVRETO ®(pralsetinib) capsules

    RIGEL PHARMACEUTICALS INC

    Patients with advanced or metastatic solid tumors

    approved small molecule active

    1 trial

  21. GEMCITABINE HYDROCHLORIDE, CISPLATIN, AVELUMAB, CISPLATIN, CISPLATIN, CISPLATIN, CARBOPLATIN, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE

    Fondazione Telethon ETS

    metastatic or locally advanced urothelial cancer

    approved small molecule active

    1 trial

  22. Gadoterate meglumine

    Guerbet

    Hepatocellular Carcinoma

    approved small molecule terminated

    1 trial

  23. Glivec 100 mg hard capsules, Tasigna 150 mg hard capsules

    Fondazione Telethon ETS

    Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)

    approved small molecule active

    1 trial

  24. IMFINZI 50 mg/mL concentrate for solution for infusion., Lynparza 100 mg film-coated tablets, Lynparza 150 mg film-coated tablets

    AstraZeneca

    Advanced or recurrent endometrial cancer

    approved small molecule active

    1 trial

  25. INDOCYANINE GREEN

    The George Institute

    Patients with liver tumors that will undergo minimally invasive liver surgery

    approved small molecule active

    1 trial

  26. INDOCYANINE GREEN

    Disc Medicine

    cervical cancer stage I-IIA

    approved small molecule active

    1 trial

  27. Ibrutinib

    AbbVie Deutschland GmbH & Co. KG

    1. Follicular Lymphoma 2. Chronic Lymphocytic Leukemia 3. Waldenstrom macroglobulinemia 4. Multiple Myeloma 5. Marginal Zone Lymphoma 6. Diffuse Large B-Cell Lymphoma 7. Urothelial Carcinoma 8. Breast Cancer 9. Acute Myeloid Leukemia 10. Graft vs Host Disease 11. Mantle Cell Lymphoma

    approved small molecule active

    1 trial

  28. Ilaprazole

    Yang Xiaotian

    Gastric Cancer

    approved small molecule completed

    1 trial

  29. Intrathecal (injected into the spinal fluid) DepoCyt

    Pacira Ireland Limited

    Meningeal Neoplasms

    approved small molecule completed

    1 trial

  30. Iomeron 400 mgI/ml solution for injection

    The George Institute

    Thoracic neoplasm

    approved small molecule active

    1 trial

  31. Irinotecan liposomes combined with cisplatin/carboplatin

    The First People's Hospital of Lianyungang

    Neuroendocrine Tumors

    approved small molecule active

    1 trial

  32. Jejunostomy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Cancer

    approved other active

    1 trial

  33. KANG FU PEN

    The First People's Hospital of Lianyungang

    Cervical Cancer

    approved small molecule active

    1 trial

  34. LENVATINIB, NIVOLUMAB, CABOZANTINIB, LENVATINIB, NIVOLUMAB, AXITINIB, CABOZANTINIB, PEMBROLIZUMAB, IPILIMUMAB, AXITINIB, AXITINIB

    Fondazione Telethon ETS

    metastatic or locally advanced renal cell carcinoma

    approved small molecule active

    1 trial

  35. LETROZOLE, RIBOCICLIB, GOSERELIN ACETATE, LEE011, TAMOXIFEN

    Novartis Pharmaceuticals

    HR+, HER2- advanced or metastatic breast cancer

    approved small molecule active

    1 trial

  36. LORLATINIB

    Pfizer Australia Pty Ltd

    Lung cancer

    approved small molecule active

    1 trial

  37. Ledipasvir 90mg/Sofosbuvir 400 mg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule terminated

    1 trial

  38. Lutrate Depot Trimestral 22,5 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 150 mg film-coated tablets, Femara 2.5 mg Tablets, Arimidex® 1 mg film-coated tablets, Zoladex 10,8 mg implantat, Aromasil 25 mg comprimidos recubiertos, Verzenios 100 mg film-coated tablets, Zoladex 3,6 mg implantat, Kisqali 200 mg film-coated tablets, Lutrate Depot Mensual 3,75 mg polvo y disolvente para suspensión inyectable de liberación prolongada, Verzenios 50 mg film-coated tablets

    Ningbo Cancer Hospital

    Early Breast Cancer

    approved small molecule active

    1 trial

  39. METHADONE , Suboxone 2 mg/0.5 mg sublingual tablets

    Disc Medicine

    Opioid use disorder (DSM-5); chronic non-cancer pain (ICD-11).

    approved small molecule active

    1 trial

  40. MORPHINE , EDOXABAN , ENZALUTAMIDE

    Disc Medicine

    Prostate cancer

    approved small molecule active

    1 trial

  41. MedPulser Electroporation with bleomycin

    INOVIO PHARMACEUTICALS, INC.

    Cancer

    approved other completed

    1 trial

  42. Medpulser electroporation with Bleomycin

    INOVIO PHARMACEUTICALS, INC.

    Head and Neck Cancer

    approved other terminated

    2 trials

  43. Mekinist, DRB436, DRB436, TMT212, TMT212, Mekinist 0.5 mg film-coated tablets, DRB436, Mekinist 2 mg film-coated tablets

    Novartis Pharmaceuticals

    Children and Adolescents with Cancers Harboring V600 mutation.

    approved small molecule active

    1 trial

  44. NIVOLUMAB

    Disc Medicine

    Melanoma, Renal cell carcinoma

    approved small molecule active

    1 trial

  45. Niraparib

    Takeda

    Epithelial Ovarian Cancer

    approved small molecule active

    1 trial

  46. ONTAK (denileukin difitox, DAB389IL-2)

    LIGAND PHARMACEUTICALS INC

    Lymphoma, T-Cell, Cutaneous

    approved small molecule completed

    1 trial

  47. OPDIVO 10 mg/mL concentrate for solution for infusion., CABOMETYX 20 mg film-coated tablets, CABOMETYX 40 mg film-coated tablets

    The George Institute

    Renal carcinoma

    approved small molecule active

    1 trial

  48. OROS hydromorphone

    Janssen Cilag International NV

    Cancer Pain

    approved small molecule completed

    1 trial

Frequently asked questions

How many oncology pipeline programs are tracked?

5,568 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.